wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40846805-30588B70-BB69-4246-B69B-FFD9282C9A59
Q40846805-30588B70-BB69-4246-B69B-FFD9282C9A59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-30588B70-BB69-4246-B69B-FFD9282C9A59
Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma.
P2860
Q40846805-30588B70-BB69-4246-B69B-FFD9282C9A59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-30588B70-BB69-4246-B69B-FFD9282C9A59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bdbac4b5ed724e799dd764b7accbc88e20ca1844
P2860
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.